Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Cardinal Health Inc    CAH

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Cardinal Health to Buy Medical-Supplies Provider AssuraMed for $2.07 Billion

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/14/2013 | 02:08pm CEST
   By Melodie Warner 
 

Cardinal Health Inc. (>> Cardinal Health, Inc.) agreed to acquire closely held medical-supplies provider AssuraMed for $2.07 billion as the drug wholesaler looks to diversify its offerings.

AssuraMed currently serves more than one million patients nationally with more than 30,000 products. The company bought Invacare Corp.'s (>> Invacare Corporation) domestic medical supplies business for $150 million last month. Including that business, Cardinal Heath said AssuraMed had 2012 revenue of $1 billion.

After the transaction is complete, Cardinal Health will supply ostomy, diabetes, insulin therapy, urological, wound care and incontinence products to the home-healthcare market.

"This is a platform opportunity for Cardinal Health products and services which will be increasingly important as the delivery of care migrates to more cost-effective settings," said Chairman and Chief Executive George Barrett.

Cardinal Health expects AssuraMed to add two cents to three cents a share to its fiscal 2013 adjusted earnings, assuming the deal closes by early April.

The company also estimates its will boost fiscal 2014 adjusted earnings by at least 18 cents a share.

Cardinal has previously disclosed the loss of its contract with pharmacy-benefits manager Express Scripts Holding Co. (>> Express Scripts Holding Co) to rival AmerisourceBergen Corp. (>> AmerisourceBergen Corp.). Two of Cardinal's huge drug-distribution customers, Walgreen Co. (>> Walgreen Company) and CVS Caremark Corp. (>> CVS Caremark Corporation), have contracts set to end this summer.

The company earlier this month reported its fiscal second-quarter earnings rose 16% as improved margins helped to offset weaker revenue at its pharmaceutical division, which was caused partly by generic-drug introductions.

Shares closed Wednesday at $45.44 and were inactive premarket. The stock has risen 8% over the past year.

Write to Melodie Warner at [email protected]

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CARDINAL HEALTH INC
05/16 INSIDER TRADING ACTIVITY CARDINAL HE : CAH) – CEO Sold 23,270 shares of St..
05/15 CARDINAL HEALTH : Congress probes WV opioid shipments
05/11 CARDINAL HEALTH : Patient Safety Advocate Earned Cardinal Health urEssential Lab..
05/10 CARDINAL HEALTH : Congressional panel probes opioid firms, DEA
05/03 CARDINAL HEALTH : Board of Directors Approves Quarterly Dividend
05/03 CARDINAL HEALTH : Attorneys, judge meet to sort out drug cases
05/01 CARDINAL HEALTH INC (NYSE : CAH) reported earnings of $1.53 per share beating Wa..
05/01 CARDINAL HEALTH : beats 3Q profit forecasts
05/01 CARDINAL HEALTH, INC. (NYSE : CAH) Files An 8-K Results of Operations and Financ..
05/01 CARDINAL HEALTH INC : Results of Operations and Financial Condition (form 8-K)
More news
Sector news : Drug Retailers - NEC
05/17DJCVS HEALTH : Why Your Pharmacy May Be Texting You -- WSJ
05/15 SHANGHAI PHARMACEUTICALS : Advent, Shanghai Pharma have not approached Stada - s..
05/02 CVS HEALTH : profit beats as pharmacy margins rise
05/02DJCVS HEALTH : Profit Declines in First Quarter of 'Rebuilding Year'
04/26 PayPal's profit, revenue beat on higher processing volumes
More sector news : Drug Retailers - NEC
News from SeekingAlpha
05/23 Why Cardinal Health Is The Top Healthcare Stock For The Rest Of 2017
05/22 My 83 Stock Portfolio Requirements And Listing Of Do Not Sell, Core And Specu..
05/19 Dividend Yields Also Drown In Floods
05/18 McKesson FQ4 top line up 4%, earnings up 733%; cash flow up 29%; shares up 6%..
05/17 Premarket analyst action - healthcare
Advertisement
Financials ($)
Sales 2017 129 843 M
EBIT 2017 2 801 M
Net income 2017 1 415 M
Debt 2017 2 933 M
Yield 2017 2,39%
P/E ratio 2017 16,72
P/E ratio 2018 15,30
EV / Sales 2017 0,20x
EV / Sales 2018 0,19x
Capitalization 23 198 M
More Financials
Chart CARDINAL HEALTH INC
Duration : Period :
Cardinal Health Inc Technical Analysis Chart | CAH | US14149Y1082 | 4-Traders
Full-screen chart
Technical analysis trends CARDINAL HEALTH INC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Average target price 76,1 $
Spread / Average Target 3,6%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
George S. Barrett Chairman & Chief Executive Officer
Michael C. Kaufmann Chief Financial Officer
Patricia B. Morrison Chief Information Officer & Executive VP
Calvin Ramarro Darden Independent Director
Gregory B. Kenny Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CARDINAL HEALTH INC1.57%23 198
WALGREENS BOOTS ALLIAN..-2.43%87 287
CVS HEALTH CORP-3.75%77 378
EXPRESS SCRIPTS HOLDIN..-12.98%36 073
MCKESSON CORPORATION14.80%34 242
AMERISOURCEBERGEN CORP..15.07%19 894
More Results